Phenylmethanesulfonic Acid

Phenylmethanesulfonic Acid

SCHEMBL3868764

O=S(=O)(O)Cc1ccccc1.[HH]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 3/20 0.56
▸ PRSS1 P07477 3/20 0.56
▸ PRSS2 P07478 3/20 0.56
▸ PRSS3 P35030 3/20 0.56
▸ CA1 P00915 2/20 0.56
▸ FAAH O00519 1/20 0.56
▸ ELANE P08246 1/20 0.56
▸ PRTN3 P24158 1/20 0.56
▸ CA5A P35218 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ MMP1 P03956 1/20 0.56
▸ MMP2 P08253 1/20 0.56
▸ MMP9 P14780 1/20 0.56
▸ MMP8 P22894 1/20 0.56
▸ MMP13 P45452 1/20 0.56
▸ F2 P00734 2/20 0.50
▸ HSP90AA1 P07900 1/20 0.50
▸ KMT2A Q03164 1/20 0.48
▸ TSHR P16473 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylmethanesulfonic Acid SCHEMBL30217949 0.97 CA2 (0.58) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL28294303 0.97 CA2 (0.58) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL1749 0.97 CA2 (0.58) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL127384 0.97 CA2 (0.58) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL3917283 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL11411737 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL5399345 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL7812774 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL21811372 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1
Phenylmethanesulfonic Acid SCHEMBL1614254 0.95 CA2 (0.56) CA2PRSS1PRSS2PRSS3CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2849568-A1 PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2015-03-25 — — EP disclosed
EP-2686401-A1 MESOGEN-CONTAINING COMPOUNDS Transitions Optical, Inc. (US) 2014-01-22 — — EP disclosed
WO-2013169348-A1 PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2013-11-14 — — WO disclosed
WO-2012128944-A1 MESOGEN-CONTAINING COMPOUNDS TRANSITIONS OPTICAL, INC. (US) 2012-09-27 — — WO disclosed
EP-2035566-A2 MATERIALS AND COMPLEXES FOR THE DELIVERY OF BIOLOGICALLY-ACTIVE MATERIAL TO CELLS University College London (GB) 2009-03-18 — — EP disclosed
WO-2007138324-A2 MATERIALS AND COMPLEXES FOR THE DELIVERY OF BIOLOGICALLY-ACTIVE MATERIAL TO CELLS UNIVERSITY COLLEGE LONDON (GB) 2007-12-06 — — WO disclosed
EP-1077959-A1 MORPHOLINO ETHERS Glaxo Wellcome S.A. (ES) 2001-02-28 — — EP disclosed
WO-1999058512-A1 MORPHOLINO ETHERS GLAXO WELLCOME S.A. (ES) 1999-11-18 — — WO disclosed
US-5949130-A Semiconductor integrated circuit device employing interlayer insulating film with low dielectric constant FUJITSU LIMITED (JP) 1999-09-07 — — US disclosed
US-5541327-A Preparation of camptothecin analogs SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1996-07-30 — — US disclosed
US-5525731-A CYCLIZATION; HALOGENATION; ALKYLATION; REDUCTION; HYDROLYSIS; DECARBOXYLATION; SELENYLATION SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1996-06-11 — — US disclosed
US-5446047-A Anticancer agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1995-08-29 — — US disclosed
US-5391745-A Cytotoxic activity towards cancer cells SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1995-02-21 — — US disclosed
WO-1994011376-A1 CAMPTOTHECIN ANALOGUES AND METHODS OF PREPARATION THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-05-26 — — WO disclosed
Send feedback